Technical Analysis for LOXO - Loxo Oncology, Inc.

Grade Last Price % Change Price Change
grade A 233.5 0.11% 0.25
LOXO closed up 0.11 percent on Friday, January 18, 2019, on 1.46 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical LOXO trend table...

Date Alert Name Type % Chg
Jan 8 New Uptrend Bullish 0.52%
Jan 8 Volume Surge Other 0.52%
Jan 8 Calm After Storm Range Contraction 0.52%
Jan 8 Narrow Range Bar Range Contraction 0.52%
Jan 8 NR7 Range Contraction 0.52%
Jan 8 NR7-2 Range Contraction 0.52%
Jan 8 Parabolic Rise Strength 0.52%
Jan 8 Stochastic Reached Overbought Strength 0.52%
Jan 8 Upper Bollinger Band Walk Strength 0.52%
Jan 8 Inside Day Range Contraction 0.52%

Older signals for LOXO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Loxo Oncology, Inc., a development-stage company, develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its lead product candidate includes LOXO-101, an oral and selective inhibitor of tropomyosin receptor kinase, which is in a Phase I dose escalation trial for the treatment of patients with advanced solid tumor types, such as neuroblastoma and lung, thyroid, and breast cancers. The company is also developing a pipeline of additional product candidates targeting cancers driven by genetic alterations. Loxo Oncology, Inc. has a drug discovery collaboration agreement with Array BioPharma Inc. The company was founded in 2013 and is headquartered in Stamford, Connecticut.
Is LOXO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 233.9
52 Week Low 85.21
Average Volume 1,061,392
200-Day Moving Average 160.822
50-Day Moving Average 162.0638
20-Day Moving Average 183.799
10-Day Moving Average 232.859
Average True Range 7.3999
ADX 46.95
+DI 53.8459
-DI 8.9797
Chandelier Exit (Long, 3 ATRs ) 211.7003
Chandelier Exit (Short, 3 ATRs ) 147.1997
Upper Bollinger Band 282.1117
Lower Bollinger Band 85.4863
Percent B (%b) 0.75
BandWidth 106.978493
MACD Line 25.3322
MACD Signal Line 20.0284
MACD Histogram 5.3039
Fundamentals Value
Market Cap 6.96 Billion
Num Shares 29.8 Million
EPS -4.18
Price-to-Earnings (P/E) Ratio -55.86
Price-to-Sales 0.00
Price-to-Book 5.55
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 234.01
Resistance 3 (R3) 233.98 233.79 233.93
Resistance 2 (R2) 233.79 233.66 233.80 233.90
Resistance 1 (R1) 233.64 233.58 233.55 233.67 233.87
Pivot Point 233.45 233.45 233.40 233.46 233.45
Support 1 (S1) 233.30 233.32 233.21 233.33 233.13
Support 2 (S2) 233.11 233.24 233.12 233.10
Support 3 (S3) 232.96 233.11 233.08
Support 4 (S4) 232.99